OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Emerging roles of oxyntomodulin-based glucagon-like peptide-1/glucagon co-agonist analogs in diabetes and obesity
Zhihong Yao, Wang Chen, Zhu Qianqian, et al.
Peptides (2023) Vol. 162, pp. 170955-170955
Closed Access | Times Cited: 10
Zhihong Yao, Wang Chen, Zhu Qianqian, et al.
Peptides (2023) Vol. 162, pp. 170955-170955
Closed Access | Times Cited: 10
Showing 10 citing articles:
Effects of dietary fibre on metabolic health and obesity
Edward C. Deehan, Valentin Mocanu, Karen Madsen
Nature Reviews Gastroenterology & Hepatology (2024) Vol. 21, Iss. 5, pp. 301-318
Closed Access | Times Cited: 24
Edward C. Deehan, Valentin Mocanu, Karen Madsen
Nature Reviews Gastroenterology & Hepatology (2024) Vol. 21, Iss. 5, pp. 301-318
Closed Access | Times Cited: 24
Glucagon-like peptide-1 analogs: Miracle drugs are blooming?
Binbin Gong, Zhihong Yao, Chenxu Zhou, et al.
European Journal of Medicinal Chemistry (2024) Vol. 269, pp. 116342-116342
Closed Access | Times Cited: 8
Binbin Gong, Zhihong Yao, Chenxu Zhou, et al.
European Journal of Medicinal Chemistry (2024) Vol. 269, pp. 116342-116342
Closed Access | Times Cited: 8
Glucagon-Like Peptide-1 Based Therapies: A New Horizon in Obesity Management
Jang Won Son, Soo Lim
Endocrinology and Metabolism (2024) Vol. 39, Iss. 2, pp. 206-221
Open Access | Times Cited: 5
Jang Won Son, Soo Lim
Endocrinology and Metabolism (2024) Vol. 39, Iss. 2, pp. 206-221
Open Access | Times Cited: 5
Pharmaceutical Strategies to Improve Druggability of Potential Drug Candidates in Nonalcoholic Fatty Liver Disease Therapy
Reeju Amatya, Dong-Hee Lee, Kyoung Ah Min, et al.
Pharmaceutics (2023) Vol. 15, Iss. 7, pp. 1963-1963
Open Access | Times Cited: 7
Reeju Amatya, Dong-Hee Lee, Kyoung Ah Min, et al.
Pharmaceutics (2023) Vol. 15, Iss. 7, pp. 1963-1963
Open Access | Times Cited: 7
Duodenal enteroendocrine cells and GIP as treatment targets for obesity and type 2 diabetes
Clifford J. Bailey, Peter R. Flatt
Peptides (2024) Vol. 174, pp. 171168-171168
Closed Access | Times Cited: 1
Clifford J. Bailey, Peter R. Flatt
Peptides (2024) Vol. 174, pp. 171168-171168
Closed Access | Times Cited: 1
Computational Peptide Design Cotargeting Glucagon and Glucagon-like Peptide-1 Receptors
Shubham Vishnoi, Shayon Bhattacharya, Erica M. Walsh, et al.
Journal of Chemical Information and Modeling (2023) Vol. 63, Iss. 15, pp. 4934-4947
Open Access | Times Cited: 3
Shubham Vishnoi, Shayon Bhattacharya, Erica M. Walsh, et al.
Journal of Chemical Information and Modeling (2023) Vol. 63, Iss. 15, pp. 4934-4947
Open Access | Times Cited: 3
Innovative approaches to the treatment of obesity: from pharmacotherapy to nanomedicine
Т. И. Романцова
Obesity and metabolism (2024) Vol. 21, Iss. 4, pp. 389-404
Open Access
Т. И. Романцова
Obesity and metabolism (2024) Vol. 21, Iss. 4, pp. 389-404
Open Access
Oxyntomodulin physiology and its therapeutic development in obesity and associated complications
Martin Tze Wah Kueh, Ming Chuen Chong, Alexander D. Miras, et al.
The Journal of Physiology (2024)
Open Access
Martin Tze Wah Kueh, Ming Chuen Chong, Alexander D. Miras, et al.
The Journal of Physiology (2024)
Open Access
Biotechnology Revolution Shaping the Future of Diabetes Management
Nilima Rajpal Kundnani, Bogdan M. Lolescu, Anca Dinu, et al.
Biomolecules (2024) Vol. 14, Iss. 12, pp. 1563-1563
Open Access
Nilima Rajpal Kundnani, Bogdan M. Lolescu, Anca Dinu, et al.
Biomolecules (2024) Vol. 14, Iss. 12, pp. 1563-1563
Open Access
Multi‐target Peptides for the Treatment of Metabolic Diseases
Martin Bossart, Gerhard Heßler
(2024), pp. 269-288
Closed Access
Martin Bossart, Gerhard Heßler
(2024), pp. 269-288
Closed Access
